Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Singulair in acute persistent cough (MAC)
NCT01279668Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in cough, pertussis, sponsored by University of Oxford. Status: unknown.
02
Drugs
montelukast
03
Conditions
coughpertussis
Beyond the preview
Go deeper on NCT01279668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279668.